Scleritis: Clinical Trials

2 trials for Scleritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Unknown 2

Follow Scleritis: new trials by email Literature Review of Scleritis trials Research Report on Scleritis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tofacitinib for Inflammatory Eye Disease
tofacitinib - Uveitis, Scleritis
Phase 2UnknownWashington University School of Medicine52019-04-042021-02-01
A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis
ACTH (adrenocorticotropic hormone) gel - Scleritis
Phase 2UnknownMetropolitan Eye Research & Surgery Institute302019-01-012023-10-23

Narrower conditions

Uveitis (1)

Broader conditions

Eye Diseases (2)  ·  Scleral Diseases (2)  ·  Uveal Diseases (1)

Interventions

5-(tetradecyloxy)-2-furancarboxylic acid (1)  ·  Adrenocorticotropic Hormone (1)  ·  Gels (1)  ·  tofacitinib (1)

Sponsors

Metropolitan Eye Research & Surgery Institute (1)  ·  Washington University School of Medicine (1)

Countries

United States (2)

Top investigators

David K Scales, MD (1)  ·  David S. Chu, MD (1)  ·  Lynn M Hassman, MD PhD (1)  ·  Quan D Nguyen, MD, MSc (1)